Recall Record

New Paltz, NY, United States

Ultra Seal Corporation recalls

3 recalls recorded since 2018, most recently on 24 January 2022. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)0
Terminated or completed3
Class I (FDA)0

Terminated Class II Drugs

Recall started
24 January 2022
Terminated
16 October 2023
Reason
cGMP deviations
Distribution
Nationwide within the United States
Initiated
Voluntary: Firm initiated
Recall numbers
D-0497-2022, D-0482-2022, D-0506-2022, D-0487-2022, D-0502-2022, D-0466-2022, D-0516-2022, D-0467-2022, D-0473-2022, D-0474-2022, D-0483-2022, D-0493-2022 and 44 more

Terminated Class III Drugs

Recall started
13 October 2021
Terminated
28 March 2022
Reason
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Distribution
Nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0075-2022, D-0077-2022, D-0071-2022, D-0072-2022, D-0073-2022, D-0074-2022, D-0076-2022, D-0070-2022

Terminated Class III Drugs

Recall started
3 August 2020
Terminated
16 March 2021
Reason
Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.
Distribution
Product was shipped to two distributors in IL and TX who may have further repackaged and distributed the product.
Initiated
Voluntary: Firm initiated
Recall numbers
D-1512-2020, D-1513-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.